These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

312 related items for PubMed ID: 17003726

  • 1. Topical pimecrolimus 1% for the treatment of pruritic external auditory canals.
    Djalilian HR, Memar O.
    Laryngoscope; 2006 Oct; 116(10):1809-12. PubMed ID: 17003726
    [Abstract] [Full Text] [Related]

  • 2. New treatment strategy and assessment questionnaire for external auditory canal pruritus: topical pimecrolimus therapy and Modified Itch Severity Scale.
    Acar B, Karabulut H, Sahin Y, Babademez MA, Karadag AS, Karasen RM.
    J Laryngol Otol; 2010 Feb; 124(2):147-51. PubMed ID: 19922703
    [Abstract] [Full Text] [Related]

  • 3. Pimecrolimus cream 1% vs. betamethasone 17-valerate 0.1% cream in the treatment of seborrhoeic dermatitis. A randomized open-label clinical trial.
    Rigopoulos D, Ioannides D, Kalogeromitros D, Gregoriou S, Katsambas A.
    Br J Dermatol; 2004 Nov; 151(5):1071-5. PubMed ID: 15541087
    [Abstract] [Full Text] [Related]

  • 4. Association between exposure to topical tacrolimus or pimecrolimus and cancers.
    Hui RL, Lide W, Chan J, Schottinger J, Yoshinaga M, Millares M.
    Ann Pharmacother; 2009 Dec; 43(12):1956-63. PubMed ID: 19903860
    [Abstract] [Full Text] [Related]

  • 5. Review of pimecrolimus cream 1% for the treatment of mild to moderate atopic dermatitis.
    Hebert AA.
    Clin Ther; 2006 Dec; 28(12):1972-82. PubMed ID: 17296454
    [Abstract] [Full Text] [Related]

  • 6. The safety and efficacy of pimecrolimus, 1%, cream for the treatment of Netherton syndrome: results from an exploratory study.
    Yan AC, Honig PJ, Ming ME, Weber J, Shah KN.
    Arch Dermatol; 2010 Jan; 146(1):57-62. PubMed ID: 20083693
    [Abstract] [Full Text] [Related]

  • 7. Topical pimecrolimus in the treatment of genital lichen planus: a prospective case series.
    Lonsdale-Eccles AA, Velangi S.
    Br J Dermatol; 2005 Aug; 153(2):390-4. PubMed ID: 16086755
    [Abstract] [Full Text] [Related]

  • 8. In reference to Topical Pimecrolimus 1% for the Treatment of Pruritic External Auditory Canals.
    Baran A, Yasemin S.
    Laryngoscope; 2007 Jul; 117(7):1319; author reply 1319. PubMed ID: 17603331
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. A randomized, single-blind, placebo-controlled, split-face study with pimecrolimus cream 1% for papulopustular rosacea.
    Karabulut AA, Izol Serel B, Eksioglu HM.
    J Eur Acad Dermatol Venereol; 2008 Jun; 22(6):729-34. PubMed ID: 18328059
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Pimecrolimus 1% cream in the treatment of facial psoriasis: a 16-week open-label study.
    Jacobi A, Braeutigam M, Mahler V, Schultz E, Hertl M.
    Dermatology; 2008 Jun; 216(2):133-6. PubMed ID: 18216475
    [Abstract] [Full Text] [Related]

  • 14. Pimecrolimus 1% cream for anogenital lichen sclerosus in childhood.
    Boms S, Gambichler T, Freitag M, Altmeyer P, Kreuter A.
    BMC Dermatol; 2004 Oct 14; 4(1):14. PubMed ID: 15485581
    [Abstract] [Full Text] [Related]

  • 15. Safety and tolerability of 1% pimecrolimus cream among infants: experience with 1133 patients treated for up to 2 years.
    Paul C, Cork M, Rossi AB, Papp KA, Barbier N, de Prost Y.
    Pediatrics; 2006 Jan 14; 117(1):e118-28. PubMed ID: 16361223
    [Abstract] [Full Text] [Related]

  • 16. Randomized trial of pimecrolimus cream versus triamcinolone acetonide paste in the treatment of oral lichen planus.
    Gorouhi F, Solhpour A, Beitollahi JM, Afshar S, Davari P, Hashemi P, Nassiri Kashani M, Firooz A.
    J Am Acad Dermatol; 2007 Nov 14; 57(5):806-13. PubMed ID: 17658663
    [Abstract] [Full Text] [Related]

  • 17. [Post-marketing surveillance on treatment of 5,665 patients with atopic dermatitis using the calcineurin inhibitor pimecrolimus: positive effects on major symptoms of atopic dermatitis and on quality of life].
    Sunderkötter C, Weiss JM, Bextermöller R, Löffler H, Schneider D.
    J Dtsch Dermatol Ges; 2006 Apr 14; 4(4):301-6. PubMed ID: 16638059
    [Abstract] [Full Text] [Related]

  • 18. Repigmentation of pretibial vitiligo with calcineurin inhibitors under occlusion.
    Hartmann A, Bröcker EB, Hamm H.
    J Dtsch Dermatol Ges; 2008 May 14; 6(5):383-5. PubMed ID: 18042249
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Topical pimecrolimus in the treatment of seborrheic dermatitis.
    Brownell I, Quan LT, Hsu S.
    Dermatol Online J; 2003 Aug 14; 9(3):13. PubMed ID: 12952760
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.